Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 29;13(10):3465.
doi: 10.3390/nu13103465.

Trend Observations in Home Parenteral Nutrition. Prevalence, Hospitalizations and Costs: Results from a Nationwide Analysis of Health Care Provider Data

Marcin Folwarski  1   2 , Stanisław Kłęk  3 , Agnieszka Szlagatys-Sidorkiewicz  4 , Adam Wyszomirski  5 , Michał Brzeziński  4 , Magdalena Skotnicka  6
Affiliations

Trend Observations in Home Parenteral Nutrition. Prevalence, Hospitalizations and Costs: Results from a Nationwide Analysis of Health Care Provider Data

Marcin Folwarski et al. Nutrients. .

Abstract

Background: The population of patients on home parenteral nutrition (HPN) worldwide is growing. Since only a few counties provide data from national registries long-term observations are valuable to address this specific area of nutrition support. This study is a nationwide analysis determining the trends in the epidemiology of HPN (prevalence, age distribution, death rates), indications for HPN, causes for hospitalizations, and cost analysis of HPN reimbursement in Poland between 2010-2020.

Methods: A retrospective analysis of data obtained from the national health fund (NHF) of Poland on adult patients on HPN.

Results: The prevalence of adult patients on HPN in Poland in 2020 was 53.26 per million citizens with a 2.99-fold increase and a growing trend observed from 2010. Significant decrease in the percentage of patients between 18-34, 45-54 and an increase in patients between 65-74 and patients over 75 years old was observed. Trend analysis showed an increase in new patients between 65-74 and a decrease between 35-54. Malnutrition (34.28%), postprocedural disorders of the GI tract (19.61%), intestinal malabsorption/other intestinal diseases (20.41%) and GI obstruction due to cancer (17.36% as primary and 23.16% as secondary diagnosis) were mostly reported as the primary indications for HPN. Cancer patients were mostly gastric, ovarian and colon cancer (34.74%, 17.83% and 12.3%). HPN and total health cost reimbursement increase was 2.6 and 2.57-fold respectively. Costs of HPN and total health care costs in 2020 per patient were € 10,015 and € 16,038, respectively. Overall death risk rate during the first year of nutrition was 0.59 with a significant increase in the observation period p-trend < 0.004. A significant increase in the death rate was observed in patients above 75 years old (estimate 1.629, p-trend < 0.030). Cancer, infection, malnutrition and GI symptoms were the most common indications for hospitalizations of HPN patients. The rate of patients with a maximal length of HPN of 5 months in 2010 was 54.9% and was growing up to 78.1% in 2020.

Conclusions: The prevalence of HPN in Poland is growing. Trends of age distribution show increasing numbers of patients with more advanced age and shorter survival. Costs of HPN are comparable with other European data.

Keywords: age distribution; cost analysis; home parenteral nutrition; nutrition; prevalence.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interest.

Figures

Figure 1
Figure 1
Prevalence of home parenteral nutrition in Poland. 1—Prevalence of HPN patients per 1 million citizens.
Figure 2
Figure 2
Age distribution. (A)—HPN patients, (B)—new qualifications.
See this image and copyright information in PMC

References

    1. Pironi L., Arends J., Baxter J., Bozzetti F., Peláez R.B., Cuerda C., Forbes A., Gabe S., Gillanders L., Holst M., et al. ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults. Clin. Nutr. 2015;34:171–180. doi: 10.1016/j.clnu.2014.08.017. - DOI - PubMed
    1. Pironi L., Arends J., Bozzetti F., Cuerda C., Gillanders L., Jeppesen P.B., Joly F., Kelly D., Lal S., Staun M., et al. ESPEN guidelines on chronic intestinal failure in adults. Clin. Nutr. 2016;35:247–307. doi: 10.1016/j.clnu.2016.01.020. - DOI - PubMed
    1. Meyer A.C., Drefahl S., Ahlbom A., Lambe M., Modig K. Trends in life expectancy: Did the gap between the healthy and the ill widen or close? BMC Med. 2020;18:41. doi: 10.1186/s12916-020-01514-z. - DOI - PMC - PubMed
    1. Maciej P., Katarzyna G.-R., Kamil K.K.W. Trwanie Życia w 2019 r., (Life Expectancy Tables of Poland 2019) Analizy Stat GUS; Warszawa, Poland: 2021.
    1. Kobza J., Geremek M. Exploring the Life Expectancy Increase in Poland in the Context of CVD Mortality Fall: The Risk Assessment Bottom-Up Approach, From Health Outcome to Policies. Inq. J. Health Care Organ. Provis. Financ. 2015;52:0046958015613091. doi: 10.1177/0046958015613091. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources